Skip to main content
Top
Published in: BMC Medical Research Methodology 1/2018

Open Access 01-12-2018 | Research article

Comparing survival functions with interval-censored data in the presence of an intermediate clinical event

Authors: Sohee Kim, Jinheum Kim, Chung Mo Nam

Published in: BMC Medical Research Methodology | Issue 1/2018

Login to get access

Abstract

Background

In the presence of an intermediate clinical event, the analysis of time-to-event survival data by conventional approaches, such as the log-rank test, can result in biased results due to the length-biased characteristics.

Methods

In the present study, we extend the studies of Finkelstein and Nam & Zelen to propose new methods for handling interval-censored data with an intermediate clinical event using multiple imputation. The proposed methods consider two types of weights in multiple imputation: 1) uniform weight and 2) the weighted weight methods.

Results

Extensive simulation studies were performed to compare the proposed tests with existing methods regarding type I error and power. Our simulation results demonstrate that for all scenarios, our proposed methods exhibit a superior performance compared with the stratified log-rank and the log-rank tests. Data from a randomized clinical study to test the efficacy of sorafenib/sunitinib vs. sunitinib/sorafenib to treat metastatic renal cell carcinoma were analyzed under the proposed methods to illustrate their performance on real data.

Conclusions

In the absence of intensive iterations, our proposed methods show a superior performance compared with the stratified log-rank and the log-rank test regarding type I error and power.
Literature
6.
9.
go back to reference Sun J. A non-parametric test for interval censored failure time data with application to aids studies. Stat Med. 1996; 15(13):1387–95. http://doi.org/10.1002/(SICI)1097-0258(19960715)15:13<1387::AID-SIM268>3.0.CO;2-R.CrossRef Sun J. A non-parametric test for interval censored failure time data with application to aids studies. Stat Med. 1996; 15(13):1387–95. http://​doi.​org/​10.​1002/​(SICI)1097-0258(19960715)15:​13<1387:​:​AID-SIM268>3.​0.​CO;2-R.CrossRef
21.
go back to reference Pan W. A two-sample test with interval censored data via multiple imputation. Stat Med. 2000; 19(1):1–11. http://doi.org/10.1002/(SICI)1097-0258(20000115)19:1<1::AID-SIM296>3.0.CO;2-Q.CrossRef Pan W. A two-sample test with interval censored data via multiple imputation. Stat Med. 2000; 19(1):1–11. http://​doi.​org/​10.​1002/​(SICI)1097-0258(20000115)19:​1<1:​:​AID-SIM296>3.​0.​CO;2-Q.CrossRef
25.
go back to reference Eichelberg C, Vervenne WL, De Santis M, Fischer von Weikersthal L, Goebell PJ, Lerchenmüller C, Zimmermann U, Bos MMEM, Freier W, Schirrmacher-Memmel S, Staehler M, Pahernik S, Los M, Schenck M, Flörcken A, van Arkel C, Hauswald K, Indorf M, Gottstein D, Michel MS. SWITCH: A randomised, sequential, open-label study to evaluate the efficacy and safety of sorafenib-sunitinib versus sunitinib-sorafenib in the treatment of metastatic renal cell cancer. Eur Urol. 2015; 68(5):837–47. https://doi.org/10.1016/j.eururo.2015.04.017. Accessed 21 Sept 2018.CrossRef Eichelberg C, Vervenne WL, De Santis M, Fischer von Weikersthal L, Goebell PJ, Lerchenmüller C, Zimmermann U, Bos MMEM, Freier W, Schirrmacher-Memmel S, Staehler M, Pahernik S, Los M, Schenck M, Flörcken A, van Arkel C, Hauswald K, Indorf M, Gottstein D, Michel MS. SWITCH: A randomised, sequential, open-label study to evaluate the efficacy and safety of sorafenib-sunitinib versus sunitinib-sorafenib in the treatment of metastatic renal cell cancer. Eur Urol. 2015; 68(5):837–47. https://​doi.​org/​10.​1016/​j.​eururo.​2015.​04.​017. Accessed 21 Sept 2018.CrossRef
Metadata
Title
Comparing survival functions with interval-censored data in the presence of an intermediate clinical event
Authors
Sohee Kim
Jinheum Kim
Chung Mo Nam
Publication date
01-12-2018
Publisher
BioMed Central
Published in
BMC Medical Research Methodology / Issue 1/2018
Electronic ISSN: 1471-2288
DOI
https://doi.org/10.1186/s12874-018-0558-y

Other articles of this Issue 1/2018

BMC Medical Research Methodology 1/2018 Go to the issue